APLA Total (Antiphospholipid Antibodies Panel)
A comprehensive test panel that detects various phospholipid antibodies, helping diagnose antiphospholipid syndrome, a condition associated with clotting disorders.
Overview of APLA Total (Antiphospholipid Antibodies Panel) in Kottayam
The APLA Total (Antiphospholipid Antibodies Panel) is a comprehensive blood test that evaluates multiple antiphospholipid antibodies and clotting-related markers associated with Antiphospholipid Syndrome (APS), an autoimmune condition that can increase the risk of abnormal blood clot formation. The panel includes tests for anticardiolipin antibodies, anti-β2 glycoprotein I antibodies, lupus anticoagulant, and specialised coagulation studies. By assessing these markers together, the test provides a detailed overview of immune activity and blood clotting patterns, helping clinicians investigate suspected autoimmune clotting disorders.
Who should get this test done?
This test may be recommended for individuals who:
● Have experienced unexplained blood clots in veins or arteries.
● Have a history of recurrent pregnancy loss or pregnancy-related complications that require further evaluation.
● Show signs or symptoms suggestive of Antiphospholipid Syndrome or another autoimmune disorder.
● Have abnormal blood clotting test results that need detailed investigation.
● Are being evaluated for autoimmune diseases such as systemic lupus erythematosus (SLE) with suspected clotting involvement.
Why consider this test?
The APLA Total Panel offers a broad assessment of antibodies and coagulation markers linked to autoimmune clotting disorders. Instead of relying on a single marker, it examines several important components that together provide a more complete understanding of the body’s immune response and clotting mechanism. This comprehensive approach supports healthcare professionals in investigating unexplained thrombotic events, recurrent pregnancy complications, or suspected autoimmune conditions, allowing for a more informed clinical evaluation and appropriate management planning.
More Information
Antiphospholipid antibodies are immune proteins that mistakenly target certain proteins attached to phospholipids, which play an important role in normal blood clotting. This panel combines antibody detection with specialised coagulation assays to evaluate different aspects of the condition from multiple angles. Because these antibodies can affect the body’s clotting process in different ways, assessing several markers together provides a more thorough picture of immune-related clotting abnormalities than a single test alone.
Other Names
● APLA Panel
● Antiphospholipid Antibody Panel
● Antiphospholipid Antibodies Profile
● APS Antibody Panel
● Antiphospholipid Syndrome (APS) Panel
● Comprehensive APLA Profile
Test included
- Cardiolipin Igg,serum
- Cardiolipin Igm,serum
- Ptt (test)
- Ptt Control (normal Pooled Plasma)
- Ptt (test+control) 1:1
- Drvv Screen (test)
- Drvv Screen Control
- Drvv Screen Ratio
- Drvv Confirmatory (test)
- Drvv Confirmatory (control)
- Drvv Confirm Ratio
- Normalised Ratio [drvv Screen Ratio / Drvv Confirm Ratio]
- Lupus Anticoagulant
- Remarks
- Anti ß2 Glycoprotein 1 Igm
- Anti ß2 Glycoprotein 1 Igg
Doctor information
Test code
4640
CPT and Loinc codes
Department
- Coagulation
- Eia - Auto Immune
Turn around time
Same Day
Performing locations
6 labs across India
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Plasma Citrate | Blue Vacutainer | 18 ML |
| Serum | Yellow Vacutainer | 12.5 ml |
Specimen stability information
Plasma Citrate, Serum
Collection instructions
CLINICAL HISTORY+ H/O ORAL Anti COAGULANT (PT. SHOULD BE OFF Anti COAGULATION FOR 7 DAYS)
Package price
₹5200
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestAPLA Total (Antiphospholipid Antibodies Panel)
₹5200